| pubmed-article:19285621 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19285621 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:19285621 | lifeskim:mentions | umls-concept:C0020542 | lld:lifeskim |
| pubmed-article:19285621 | lifeskim:mentions | umls-concept:C0442027 | lld:lifeskim |
| pubmed-article:19285621 | lifeskim:mentions | umls-concept:C0033554 | lld:lifeskim |
| pubmed-article:19285621 | lifeskim:mentions | umls-concept:C1883712 | lld:lifeskim |
| pubmed-article:19285621 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:19285621 | pubmed:dateCreated | 2009-3-16 | lld:pubmed |
| pubmed-article:19285621 | pubmed:abstractText | The aim of our study was to describe the efficacy of addition of intravenous or subscutaneous prostanoids in idiopathic pulmonary arterial hypertension (PAH) patients deteriorating on bosentan or on bosentan-sildenafil. | lld:pubmed |
| pubmed-article:19285621 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19285621 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19285621 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19285621 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19285621 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19285621 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19285621 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19285621 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19285621 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19285621 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19285621 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19285621 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19285621 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19285621 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19285621 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:19285621 | pubmed:issn | 1557-3117 | lld:pubmed |
| pubmed-article:19285621 | pubmed:author | pubmed-author:TurekM AMA | lld:pubmed |
| pubmed-article:19285621 | pubmed:author | pubmed-author:PostmusPieter... | lld:pubmed |
| pubmed-article:19285621 | pubmed:author | pubmed-author:MarcusJ TimJT | lld:pubmed |
| pubmed-article:19285621 | pubmed:author | pubmed-author:BoonstraAncoA | lld:pubmed |
| pubmed-article:19285621 | pubmed:author | pubmed-author:JacobsWouterW | lld:pubmed |
| pubmed-article:19285621 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19285621 | pubmed:volume | 28 | lld:pubmed |
| pubmed-article:19285621 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19285621 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19285621 | pubmed:pagination | 280-4 | lld:pubmed |
| pubmed-article:19285621 | pubmed:meshHeading | pubmed-meshheading:19285621... | lld:pubmed |
| pubmed-article:19285621 | pubmed:meshHeading | pubmed-meshheading:19285621... | lld:pubmed |
| pubmed-article:19285621 | pubmed:meshHeading | pubmed-meshheading:19285621... | lld:pubmed |
| pubmed-article:19285621 | pubmed:meshHeading | pubmed-meshheading:19285621... | lld:pubmed |
| pubmed-article:19285621 | pubmed:meshHeading | pubmed-meshheading:19285621... | lld:pubmed |
| pubmed-article:19285621 | pubmed:meshHeading | pubmed-meshheading:19285621... | lld:pubmed |
| pubmed-article:19285621 | pubmed:meshHeading | pubmed-meshheading:19285621... | lld:pubmed |
| pubmed-article:19285621 | pubmed:meshHeading | pubmed-meshheading:19285621... | lld:pubmed |
| pubmed-article:19285621 | pubmed:meshHeading | pubmed-meshheading:19285621... | lld:pubmed |
| pubmed-article:19285621 | pubmed:meshHeading | pubmed-meshheading:19285621... | lld:pubmed |
| pubmed-article:19285621 | pubmed:meshHeading | pubmed-meshheading:19285621... | lld:pubmed |
| pubmed-article:19285621 | pubmed:meshHeading | pubmed-meshheading:19285621... | lld:pubmed |
| pubmed-article:19285621 | pubmed:meshHeading | pubmed-meshheading:19285621... | lld:pubmed |
| pubmed-article:19285621 | pubmed:meshHeading | pubmed-meshheading:19285621... | lld:pubmed |
| pubmed-article:19285621 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19285621 | pubmed:articleTitle | Addition of prostanoids in pulmonary hypertension deteriorating on oral therapy. | lld:pubmed |
| pubmed-article:19285621 | pubmed:affiliation | Department of Pulmonology, Institute for Cardiovascular Research, VU University Medical Center, Amsterdam, The Netherlands. | lld:pubmed |
| pubmed-article:19285621 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19285621 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
